# Ocugen Inc. (OCGN) fundamentals

Data as of 2026-11-07. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $0.93, market value $314 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Ocugen Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 65.7×**. Each dollar of revenue is priced at 65.7×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -20.4%** (5-yr avg -26.8%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: 557.7%**. A 557.7% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on assets: -150.2%**. Each dollar of assets produces -150.2% of profit.

## Growth
- **Revenue growth (1 yr): 8.8%** (3-yr 21.0%/yr, 5-yr 152.5%/yr). Revenue grew 8.8% over the last year, against 152.5% a year compounded over five years: growth is slowing.

## Financial health
- **Current ratio: 1.06** (quick 1.06). Current assets cover the next year's liabilities 1.06 times.
- **Altman Z-score: -1.64**. A Z-score of -1.64 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Ocugen Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -33.0%** (YTD -31.5%, 3-mo -27.7%). The shares are down 33.0% over twelve months including dividends.
- **From 52-week high: -66.1%** (33.9% above the low). Trading 66% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 56**. An RSI of 56 is neutral.
- **Beta (1 yr): 1.62** (volatility 82%). Beta of 1.62 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OCGN · Page: https://foliofundamentals.com/stocks/ocgn

Not investment advice.